Effect of captopril on changes in rats' hearts induced by long-term irradiation. 1993

R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
Department of Pathology, Hadassah Medical School, Jerusalem, Israel.

The aim of this study was to test the efficacy of captopril, an angiotensin-converting enzyme inhibitor and a known suppressor of fibrosis, in preventing late radiation-induced cardiac pathology. Myocardial functional, histochemical and ultrastructural-morphometric studies were done on perfused hearts of rats isolated 3 and 6 months after 60Co gamma irradiation with 20 Gy and age-matched controls. At each time the animals were divided into the following groups: nonirradiated controls; irradiated once with 20 Gy; irradiated as above and given daily doses of captopril; daily doses of captopril without irradiation. The results showed that captopril, while ameliorating the decrease in the indices of capillary function, increase in mast cells, fibrosis, number of atrial granules, and changes in nerve terminals, failed to prevent the progressive functional deterioration of the hearts after irradiation. These findings suggest that an intramyofiber derangement may be involved in the long-term myocardial complications of irradiation.

UI MeSH Term Description Entries
D011833 Radiation Injuries, Experimental Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals. Experimental Radiation Injuries,Injuries, Experimental Radiation,Experimental Radiation Injury,Radiation Injury, Experimental
D011837 Radiation-Protective Agents Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. Radiation Protectant,Radiation Protective Agent,Radiation-Protective Agent,Radiation-Protective Drug,Radioprotective Agent,Radioprotective Agents,Radioprotective Drug,Agents, Radiation-Protective,Radiation Protectants,Radiation Protective Agents,Radiation-Protective Drugs,Radiation-Protective Effect,Radiation-Protective Effects,Radioprotective Drugs,Agent, Radiation Protective,Agent, Radiation-Protective,Agent, Radioprotective,Agents, Radiation Protective,Agents, Radioprotective,Drug, Radiation-Protective,Drug, Radioprotective,Drugs, Radiation-Protective,Drugs, Radioprotective,Effect, Radiation-Protective,Effects, Radiation-Protective,Protectant, Radiation,Protectants, Radiation,Protective Agent, Radiation,Protective Agents, Radiation,Radiation Protective Drug,Radiation Protective Drugs,Radiation Protective Effect,Radiation Protective Effects
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D005260 Female Females
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear
D006335 Heart Injuries General or unspecified injuries to the heart. Cardiac Rupture, Traumatic,Heart Rupture, Traumatic,Injuries, Heart,Cardiac Ruptures, Traumatic,Heart Injury,Heart Ruptures, Traumatic,Injury, Heart,Rupture, Traumatic Cardiac,Rupture, Traumatic Heart,Ruptures, Traumatic Cardiac,Ruptures, Traumatic Heart,Traumatic Cardiac Rupture,Traumatic Cardiac Ruptures,Traumatic Heart Rupture,Traumatic Heart Ruptures
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
April 2008, Sheng li xue bao : [Acta physiologica Sinica],
R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
September 1997, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
June 2013, Journal of molecular and cellular cardiology,
R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
October 1986, British journal of clinical pharmacology,
R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
January 1998, Kidney international,
R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
January 1995, Pharmacological research,
R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
February 1989, BMJ (Clinical research ed.),
R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
March 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
March 1999, Pharmacological research,
R Yarom, and I S Harper, and S Wynchank, and D van Schalkwyk, and J Madhoo, and K Williams, and R Salie, and S Genade, and A Lochner
May 2000, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!